治疗性痛风的紧急适应症。西班牙Aferesis集团（GEA）。2024年第二版

IF 2.3 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Revista clinica espanola Pub Date : 2025-05-01 DOI:10.1016/j.rce.2025.502284

I.M. Parra Salinas , J.A. García Erce , Grupo Español de Aféresis (GEA)

{"title":"治疗性痛风的紧急适应症。西班牙Aferesis集团（GEA）。2024年第二版","authors":"I.M. Parra Salinas , J.A. García Erce , Grupo Español de Aféresis (GEA)","doi":"10.1016/j.rce.2025.502284","DOIUrl":null,"url":null,"abstract":"<div><div>The Spanish Apheresis Group (GEA) presents the second edition of the “Urgent Indications for Therapeutic Apheresis” document, updated 12 years after its initial publication. This revision addresses the need to standardize its application, given the variability observed across different centers and the lack of resources in some provinces. A critical review of the most recent scientific evidence was conducted, including the latest edition of the American Society of Apheresis (ASFA) guidelines and other evidence-based recommendations. Through a methodological review and expert consensus, the list of conditions in which therapeutic apheresis—whether plasma exchange, red blood cell exchange, or cytoreductive apheresis—should be considered an urgent treatment has been redefined. This update introduces new indications and clinical scenarios where apheresis can provide significant therapeutic benefits.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 5","pages":"Article 502284"},"PeriodicalIF":2.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Indicaciones urgentes de aféresis terapéutica. Grupo Español de Aféresis (GEA). Segunda edición 2024\",\"authors\":\"I.M. Parra Salinas , J.A. García Erce , Grupo Español de Aféresis (GEA)\",\"doi\":\"10.1016/j.rce.2025.502284\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The Spanish Apheresis Group (GEA) presents the second edition of the “Urgent Indications for Therapeutic Apheresis” document, updated 12 years after its initial publication. This revision addresses the need to standardize its application, given the variability observed across different centers and the lack of resources in some provinces. A critical review of the most recent scientific evidence was conducted, including the latest edition of the American Society of Apheresis (ASFA) guidelines and other evidence-based recommendations. Through a methodological review and expert consensus, the list of conditions in which therapeutic apheresis—whether plasma exchange, red blood cell exchange, or cytoreductive apheresis—should be considered an urgent treatment has been redefined. This update introduces new indications and clinical scenarios where apheresis can provide significant therapeutic benefits.</div></div>\",\"PeriodicalId\":21223,\"journal\":{\"name\":\"Revista clinica espanola\",\"volume\":\"225 5\",\"pages\":\"Article 502284\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista clinica espanola\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0014256525000475\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014256525000475","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

西班牙单采组织（GEA）发布了“治疗单采的紧急适应症”文件的第二版，在其首次出版12年后进行了更新。鉴于在不同中心观察到的差异和一些省份缺乏资源，这次修订解决了标准化其应用的需要。对最新的科学证据进行了批判性审查，包括最新版的美国采血学会（ASFA）指南和其他循证建议。通过方法学回顾和专家共识，治疗性分离——无论是血浆交换、红细胞交换还是细胞减原性分离——应被视为紧急治疗的条件清单已被重新定义。该更新介绍了新的适应症和临床情况，其中采血可以提供显着的治疗益处。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Indicaciones urgentes de aféresis terapéutica. Grupo Español de Aféresis (GEA). Segunda edición 2024

The Spanish Apheresis Group (GEA) presents the second edition of the “Urgent Indications for Therapeutic Apheresis” document, updated 12 years after its initial publication. This revision addresses the need to standardize its application, given the variability observed across different centers and the lack of resources in some provinces. A critical review of the most recent scientific evidence was conducted, including the latest edition of the American Society of Apheresis (ASFA) guidelines and other evidence-based recommendations. Through a methodological review and expert consensus, the list of conditions in which therapeutic apheresis—whether plasma exchange, red blood cell exchange, or cytoreductive apheresis—should be considered an urgent treatment has been redefined. This update introduces new indications and clinical scenarios where apheresis can provide significant therapeutic benefits.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista clinica espanola 医学-医学：内科

CiteScore

4.40

自引率

6.90%

发文量

审稿时长

28 days

期刊介绍： Revista Clínica Española published its first issue in 1940 and is the body of expression of the Spanish Society of Internal Medicine (SEMI). The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Revista Clínica Española is subject to a thorough double blind review of the received articles written in Spanish or English. Nine issues are published each year, including mostly originals, reviews and consensus documents.